β¨ Medicines Schedule
NEW ZEALAND GAZETTE
No. 169
Folic acid; in medicines containing more than 500 mcg of folic acid per recommended daily dose
Gluacagon
Guaiphenesin; in medicines containing more than 2% of guaiphenesin
Hydrocortisone; and hydrocortisone acetate; in medicines for dermatological use containing 0.5% or less by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of not more than 15 grams or 15 millilitres per container
Hydroquinone; in medicines containing more than 2% of hydroquinone
Idoxuridine; in medicines containing 0.5% or less of idoxuridine for dermatological use
Indomethacin; in medicines for external use containing 1% or less of indomethacin
Ipecacuanha
Jaborandi, alkaloids of, and its salts; in medicines containing 0.5% or more of the alkaloids of jaborandi
Ketoconazole; for dermatological use
Ketoprofen; and its salts; in medicines for external use
Lignocaine; and its salts, in medicines for external use containing more than 2% of lignocaine
Lobelia, alkaloids of, and its salts
Loratidine
Mefenamic acid, and its salts; in solid dose forms of 250 mg or less and in a pack containing not more than 20 tablets or capsules for the treatment of dysmenorrhoea
Mequitazine
Naproxen, and its salts; in solid dose forms containing the equivalent of 250 mg of naproxen per dose form, when in a pack containing not more than 20 tablets or capsules and sold for the treatment of dysmenorrhoea
Nicotine; in medicines for transdermal use
Noradrenaline; and its salts
Nystatin; in medicines for dermatological use
Oxerutins
Oxiconazole nitrate
Paracetamol; except where specified elsewhere in this notice
Phenazone
Phenylephrine; for nasal use except when sold at an airport
Piroxicam; in medicines for external use containing 1% or less of piroxicam
Polygeline
Potassium chloride; except in medicines for oral rehydration therapy
Potassium perchlorate
Selenium, and compounds of selenium; in medicines for external use containing more than 2.5% of selenium; and in medicines for internal use where the recommended daily dose exceeds 150 micrograms of selenium
Sennosides
Sulphadiazine, and its salts; in medicines for external use when in pack sizes containing 50 g or less
Terbinafine; for external use
Thiomersal
Xylometazoline, and its salts, except when sold at an airport
Yohimbe, alkaloids of, and its salts
Fourth Schedule
General Sale Medicines
Aconite, alkaloids of, and its salts; in medicines for external use containing less than 0.02% of the alkaloids of aconite
Adrenal extract; in dermatological medicines containing 0.02% or less of ketosteroids
Aescin; in medicines for external use
Aloes; in medicines for external use
Aluminium; and its salts; in medicines for external use
Barium Sulphate
Benzoyl peroxide; in medicines for external use containing 5% or less of benzoyl peroxide
Beta carotene; in medicines containing 18 mg or less per recommended daily dose
Berberine
Bioallethrin; in medicines for external use
Butoxyethyl nicotinate
Cade oil; in medicines for external use
Calcium glucono-galacto-gluconate; except for parenteral use
Carbaryl; in medicines for external use containing 2% or less of carbaryl
Carbenoxolone, and its salts; compounds of carbenoxolone; in medicines for external use
Cardamom; compound tincture; aromatic tincture
Catechu
Choline salicylate
Chlorhexidine
Chlorphenesin
Chymotrypsin
Clioquinol; in medicines for external use
Crocus sativus; extracts of
Crotamiton
2,4-Dichlorobenzyl alcohol
Dequalinium; and its salts
Dibromopropamidine isethionate; except for ophthalmological use
Diethylamine salicylate
Dioctyl sodium sulphosuccinate
Diphenanil; and its salts
Ethyl nicotinate
Ethyl salicylate
Fenticlor; in medicines for external use
Fibrinolysin; in medicines for external use
Folic acid; in medicines containing 500 mcg or less per recommended daily dose
Glycol salicylate
Guaiphenesin; in medicines containing 2% or less of guaiphenesin
Haloprogin
Halquinol; in medicines for external use
Heparins; in medicines for external use
Hexetidine; in medicines for external but not vaginal use
Hexyl nicotinate
Histamine acid phosphate; in medicines containing 0.5% or less of histamine acid phosphate
Hyaluronidase; for external use
Hydroxocobalamin; in medicines containing 50 mcg or less of hydroxocobalamin per daily dose
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1992, No 169
NZLII —
NZ Gazette 1992, No 169
β¨ LLM interpretation of page content
π₯
Pharmacy-Only Medicines Schedule
(continued from previous page)
π₯ Health & Social WelfarePharmacy-Only Medicines, Health Regulations, Medicinal Substances
π₯ Fourth Schedule - General Sale Medicines
π₯ Health & Social WelfareGeneral Sale Medicines, Health Regulations, Medicinal Substances